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Background
Serum ferritin is a laboratory marker that reflects the level
of macrophage activation in systemic inflammatory ill-
nesses. Sharply increased levels of ferritin are usually
found in the acute phase of macrophage activation syn-
drome (MAS).
Objectives
1) To investigate the prevalence of hyperferritinemia (fer-
ritin > 500 μg/dl) in patients with systemic inflammatory
conditions who had this laboratory test requested in the
context of the diagnostic workup. 2) To determine the
prevalence of specific diagnoses among patients with
hyperferritinemia.
Results
More than 4000 determinations of ferritin requested by
the study unit were performed between January 2004 and
December 2007 by the central laboratory of the study hos-
pital. Hyperferritinemia was found in 408 determinations
in 87 patients. The most common specific diagnoses in
patients with hyperferritinemia were the following: sys-
temic juvenile idiopathic arthritis (sJIA) (48.3%), sys-
temic lupus erythematosus (SLE) (5.7%), protein
intolerance with lysinuria (4.6%), virus-associated hae-
mophagocytic syndrome (3.4%), hematologic disorders
(3.4%), juvenile dermatomyositis (2.3%), polyarticular
JIA (2.3%), systemic vasculitis (2.3%), autoinflammatory
syndrome (2.3%). Twelve patients (13.8%) had a nonspe-
cific systemic inflammatory syndrome. Twenty-seven
(31%) of the 87 patients with hyperferritinemia devel-
oped features consistent with MAS.
Conclusion
The most frequent specific diagnoses in patients with
hyperferritinemia were sJIA and SLE. However, hyperfer-
ritinemia was seen in a number of children with systemic
inflammatory syndromes, which were mainly character-
ized clinically by persistent fever, but did not fit any spe-
cific diagnostic categories and remained of undetermined
etiology. Around one third of the patients with hyperfer-
ritinemia developed features consistent with MAS.
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